Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 5/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | AR | P10275 | 2/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | HTR6 | P50406 | 1/20 | 0.52 |
| ▸ | ESRRG | P62508 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | KLF10 | Q13118 | 1/20 | 0.43 |
| ▸ | SHBG | P04278 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | PRKAB2 | O43741 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4593380 | 0.92 | CNR1 (0.48) | ESR1ESR2CYP3A4HPGDTSHR | |
| SCHEMBL10879927 | 0.84 | LMNA (0.52) | ESR1ESR2HPGDTSHRHSD17B10 | |
| SCHEMBL873489 | 0.82 | TSHR (0.52) | ESR1ESR2CYP3A4TSHRALDH1A1 | |
| SCHEMBL10476838 | 0.82 | SHBG (0.64) | ESR1ESR2CYP3A4HPGDTSHR | |
| SCHEMBL13666515 | 0.82 | CNR1 (0.43) | ESR1ESR2CYP3A4HPGDTSHR | |
| SCHEMBL1807039 | 0.80 | MEN1 (0.56) | TSHRSLC6A2SLC6A4SLC6A3CNR1 | |
| SCHEMBL394785 | 0.80 | MAPT (0.52) | ESR1ESR2CYP3A4HPGDESRRG | |
| SCHEMBL3045994 | 0.80 | CNR1 (0.42) | ESR1ESR2CYP3A4ALDH1A1CNR1 | |
| SCHEMBL186541 | 0.80 | CNR1 (0.42) | ESR1ESR2CYP3A4CNR1CNR2 | |
| SCHEMBL31556506 | 0.80 | CES2 (0.43) | CNR1CNR2TAAR1LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140350177-A1 | WATER-BORNE DISPERSIONS OF OIL MODIFIED URETHANE POLYMERS | LUBRIZOL ADVANCED MAT INC (US) | 2014-11-27 | — | — | US | claimed |
| EP-1805273-B1 | WATER-BORNE DISPERSIONS OF OIL MODIFIED URETHANE POLYMERS | LUBRIZOL ADVANCED MAT INC (US) | 2010-04-21 | — | — | EP | claimed |
| EP-1805273-A1 | WATER-BORNE DISPERSIONS OF OIL MODIFIED URETHANE POLYMERS | Noveon, Inc. (US) | 2007-07-11 | — | — | EP | claimed |
| WO-2006047746-A1 | WATER-BORNE DISPERSIONS OF OIL MODIFIED URETHANE POLYMERS | NOVEON, INC. (US) | 2006-05-04 | — | — | WO | claimed |
| US-20060089453-A1 | Water-borne dispersions of oil modified urethane polymers | LUBRIZOL ADVANCED MATERIALS, INC. | 2006-04-27 | — | — | US | claimed |
| EP-1015506-B1 | PHOSPHATIZED AMINE CHAIN-EXTENDED EPOXY POLYMERIC COMPOUNDS | PPG IND OHIO INC (US) | 2005-11-23 | — | — | EP | claimed |
| US-6403690-B1 | HALOGEN-FREE; FREE RADICALLY POLYMERIZABLE MONOMER AND A REACTIVE HYDROXY-FUNCTIONAL CYCLIC PHOSPHINATE; VARNISH FOR GLASS WOVEN FABRICS LAMINATES | MATSUSHITA ELECTRIC WORKS, LTD. (JP) | 2002-06-11 | — | — | US | claimed |
| EP-0801089-A1 | Preparation of branched polycarbonates | THE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1997-10-15 | — | — | EP | claimed |
| WO-2026104690-A1 | AQUEOUS DISPERSION OF A CROSSLINKING COMPONENT FOR CATIONIC PAINT BINDERS | ALLNEX AUSTRIA GMBH (AT) | 2026-05-21 | — | — | WO | disclosed |
| US-12630669-B2 | Waterborne epoxy curing agent | EVONIK OPERATIONS GMBH (DE) | 2026-05-19 | — | — | US | disclosed |
| EP-2794771-B2 | CORROSION RESISTANT EQUIPMENT FOR OIL AND/OR GAS APPLICATIONS | TENARIS CONNECTIONS BV (NL) | 2025-05-21 | — | — | EP | disclosed |
| US-20250066535-A1 | WATERBORNE EPOXY CURING AGENT | EVONIK OPERATIONS GMBH (DE) | 2025-02-27 | — | — | US | disclosed |
| US-12221511-B2 | Curing composition | EVONIK OPERATIONS GMBH (DE) | 2025-02-11 | — | — | US | disclosed |
| US-20250043066-A1 | AMINE COMPOSITION, EPOXY SYSTEM PREPARED FROM THE AMINE COMPOSITION AND AN EPOXY RESIN, AND USE OF THE EPOXY SYSTEM | EVONIK OPERATIONS GMBH (DE) | 2025-02-06 | — | — | US | disclosed |
| US-4730011-A | ELECTROCOATING | BASF AKTIENGESELLSCHAFT (DE) | 1988-03-08 | — | — | US | disclosed |
| EP-0106160-B1 | HEAT RESISTANT ADHESIVES ASSEMBLY MODIFIED WITH AN EPOXIDE | LORD CORPORATION (US) | 1988-01-07 | — | — | EP | disclosed |
| US-4699937-A | Synthetic resin carrying basic nitrogen groups, its preparation, coating materials produced using this resin, and cathodic electrocoating | BASF FARBEN+FASERN AKTIENGESELLSCHAFT (DE) | 1987-10-13 | — | — | US | disclosed |
| US-4548965-A | POLYEPOXIDES CONTAINING AMINES, CROSSLINKED AND MODIFIED BY BRANCHED POLYOXYALKYLENE GLYCOL; FLEXIBILITY | BASF FARBEN & FASERN AG (DE) | 1985-10-22 | — | — | US | disclosed |
| US-4467071-A | UNSATURATED ORGANOPHOSPHORUS PARTIAL ESTER, REDOX CATALYST | LORD CORPORATION (US) | 1984-08-21 | — | — | US | disclosed |
| EP-0106160-A2 | Heat resistant adhesives assembly modified with an epoxide | LORD CORPORATION (US) | 1984-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630669-B2 | Waterborne epoxy curing agent | PNMT, EPHX2, EPHX1 | ESR1 185/4885ESR2 235/4885CYP3A4 2939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.